Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Ratio | 1 | 2014 | 4 | 0.490 |
Why?
|
| Cell Cycle | 3 | 2017 | 326 | 0.380 |
Why?
|
| Nocodazole | 1 | 2010 | 9 | 0.360 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 448 | 0.360 |
Why?
|
| Tubulin Modulators | 1 | 2010 | 18 | 0.360 |
Why?
|
| Paclitaxel | 1 | 2010 | 50 | 0.350 |
Why?
|
| Quercetin | 1 | 2010 | 45 | 0.340 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 110 | 0.320 |
Why?
|
| Campylobacter jejuni | 1 | 2006 | 22 | 0.290 |
Why?
|
| Food Handling | 1 | 2006 | 33 | 0.280 |
Why?
|
| Chickens | 1 | 2006 | 133 | 0.270 |
Why?
|
| Indoles | 2 | 2017 | 158 | 0.250 |
Why?
|
| Transforming Growth Factor beta | 3 | 2004 | 197 | 0.250 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 186 | 0.240 |
Why?
|
| Bleomycin | 2 | 2000 | 20 | 0.230 |
Why?
|
| NF-kappa B | 2 | 2017 | 339 | 0.230 |
Why?
|
| Food Microbiology | 2 | 2013 | 34 | 0.220 |
Why?
|
| Food Contamination | 2 | 2013 | 55 | 0.210 |
Why?
|
| Connective Tissue | 1 | 2000 | 9 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2000 | 67 | 0.180 |
Why?
|
| Fibrinolysin | 1 | 1999 | 8 | 0.180 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 34 | 0.170 |
Why?
|
| Neoplasms | 1 | 2010 | 1103 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2000 | 61 | 0.170 |
Why?
|
| Thrombospondin 1 | 1 | 1999 | 23 | 0.170 |
Why?
|
| Camptothecin | 1 | 2017 | 20 | 0.150 |
Why?
|
| Cell Death | 1 | 2017 | 267 | 0.140 |
Why?
|
| DNA, Bacterial | 2 | 2013 | 186 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 356 | 0.130 |
Why?
|
| Inflammation | 1 | 2000 | 618 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1198 | 0.120 |
Why?
|
| Ethiopia | 1 | 2014 | 9 | 0.120 |
Why?
|
| Insemination, Artificial | 1 | 2014 | 9 | 0.120 |
Why?
|
| Breeding | 1 | 2014 | 21 | 0.120 |
Why?
|
| Bacteria, Aerobic | 1 | 2013 | 7 | 0.120 |
Why?
|
| Meat Products | 1 | 2013 | 5 | 0.120 |
Why?
|
| Apoptosis | 3 | 2017 | 1398 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 562 | 0.110 |
Why?
|
| Cattle | 1 | 2014 | 477 | 0.110 |
Why?
|
| Cell Survival | 2 | 2010 | 864 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2014 | 534 | 0.110 |
Why?
|
| Animals | 6 | 2015 | 15081 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2231 | 0.100 |
Why?
|
| Ruta | 1 | 2011 | 3 | 0.100 |
Why?
|
| Time Factors | 2 | 2017 | 1742 | 0.090 |
Why?
|
| Food-Drug Interactions | 1 | 2010 | 4 | 0.090 |
Why?
|
| Cyclin B1 | 1 | 2010 | 16 | 0.090 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 58 | 0.090 |
Why?
|
| G2 Phase | 1 | 2010 | 29 | 0.090 |
Why?
|
| Tubulin | 1 | 2010 | 88 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2010 | 212 | 0.080 |
Why?
|
| Bacteria | 1 | 2012 | 255 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 269 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2017 | 1908 | 0.080 |
Why?
|
| Microtubules | 1 | 2010 | 120 | 0.080 |
Why?
|
| DNA Damage | 1 | 2011 | 352 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2011 | 286 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 213 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 803 | 0.080 |
Why?
|
| Industrial Waste | 1 | 2006 | 16 | 0.070 |
Why?
|
| Computer Systems | 1 | 2006 | 19 | 0.070 |
Why?
|
| Calibration | 1 | 2006 | 56 | 0.070 |
Why?
|
| Reference Values | 1 | 2006 | 212 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 502 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1618 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 1 | 2004 | 31 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 46 | 0.060 |
Why?
|
| Female | 4 | 2014 | 20969 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2011 | 859 | 0.060 |
Why?
|
| DNA Primers | 2 | 2013 | 286 | 0.050 |
Why?
|
| Rats | 2 | 2000 | 3483 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 539 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2000 | 56 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2000 | 47 | 0.050 |
Why?
|
| Cell Count | 1 | 2000 | 135 | 0.050 |
Why?
|
| Fibronectins | 1 | 2000 | 66 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2000 | 102 | 0.040 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 1999 | 6 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 52 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 35 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 20 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 935 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 172 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2004 | 681 | 0.040 |
Why?
|
| Humans | 5 | 2017 | 37093 | 0.040 |
Why?
|
| Body Weight | 1 | 2000 | 434 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 3 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2017 | 27 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 448 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 290 | 0.040 |
Why?
|
| Male | 2 | 2014 | 20025 | 0.040 |
Why?
|
| Caspases | 1 | 2017 | 147 | 0.040 |
Why?
|
| Lung | 1 | 2000 | 446 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 177 | 0.040 |
Why?
|
| Macrophages | 1 | 2000 | 439 | 0.040 |
Why?
|
| Proteins | 1 | 1999 | 369 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2015 | 35 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 1999 | 1518 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 60 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 51 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1039 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 259 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2013 | 26 | 0.030 |
Why?
|
| Bioterrorism | 1 | 2012 | 20 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 571 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2012 | 114 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 21 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 92 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 189 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 68 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 207 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 5913 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 444 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 807 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 399 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1568 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 644 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 441 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2004 | 10 | 0.020 |
Why?
|
| Actins | 1 | 2004 | 148 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 93 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 617 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 935 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1502 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 1609 | 0.010 |
Why?
|